Healthcare News

OSLO, Noruega, July 17, 2026 (GLOBE NEWSWIRE) -- A Society for Medical Decision Making (SMDM) entregou sua maior homenagem a carreiras, o 2026 Career Achievement Award, ao professor Uwe Siebert,...

OSLO, Noruega, July 17, 2026 (GLOBE NEWSWIRE) -- La Society for Medical Decision Making (SMDM) presentó su máximo reconocimiento a la trayectoria profesional, el Premio a la Trayectoria Profesional...

กรุงออสโล ประเทศนอร์เวย์, July 18, 2026 (GLOBE NEWSWIRE) -- Society for Medical Decision Making (SMDM) ได้มอบรางวัลเกียรติยศสูงสุดในวิชาชีพ ได้แก่ รางวัลความสำเร็จในวิชาชีพประจำปี 2026 ให้แก่...

SAN CARLOS, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...

Châtillon, France, July 17, 2026 DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market:...

Châtillon, France, le 17 juillet 2026 DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars DBV Technologies...

Rapid oral presentation to highlight overall survival data from the DENALI Part 1b study of azenosertib SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL),...

WALTHAM, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in...

CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of...

EMERYVILLE, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted...